Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma
byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef
Updated on: January 13,2024
Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma
byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef
Updated on:January 13,2024
